Technology | Advanced Visualization | June 30, 2016

Vital Introduces Vitrea 7 Advanced Visualization Platform

Latest release offers patient-centric, application-based solutions for 2-D, 3-D and 4-D medical imaging and workflows

Vital Images, Vitrea 7 advanced visualization software, SCCT 2016

June 30, 2016 — Vital Images Inc. recently launched version 7 of its Vitrea advanced visualization software. This application-based platform delivers full-powered solutions for 2-D, 3-D and 4-D medical imaging and comprehensive user workflows, including computed tomography (CT), magnetic resonance (MR) and X-ray angiography (XA) applications.

Vitrea software is one of several solutions Vital featured at the Society of Cardiovascular Computed Tomography (SCCT) annual meeting, June 23-26 in Orlando, Fla.

With several new applications and unified, scalable deployment options, Vitrea software empowers chief medical informatics officers (CMIOs) and their clinicians to grow their applications based on current and future needs. The flexibility of partner applications being available on all deployments and content personalization built into Vitrea software can help CMIOs gain more rapid physician adoption.

Vital also streamlined the user interface and integration of new applications to ensure consistent user experience across all modalities (CT, MR, XA, positron emission tomography and single photon emission computed tomography). By providing advanced clinical tools within a uniform user interface, Vitrea software enables physicians to have meaningful interactions wherever they are.

At SCCT, Vital showcased a Stratasys uPrint SE Plus 3-D Printer, which is able to physically replicate the anatomy using data from an imaging study. Vitrea software takes patient scans and converts them into STL files for direct use with a 3-D printer. A range of anatomical models from demonstration patient studies were on display as well. Many of these models were 3-D printed using Stratasys’ Connex line of 3-D printers that enables simultaneous multi-material, multi-color 3-D prints to mimic both the appearance and texture of patient anatomy.

For more information: www.vitalimages.com

Related Content

The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer | October 21, 2020
October 21, 2020 — Quantib, a market leader in...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

56-Year-Old Woman With Benign Hemangioma: Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma.

News | Magnetic Resonance Imaging (MRI) | October 16, 2020
October 16, 2020 —